Halliburton offered 1.71 billion pounds, or $3.4 billion, for the Expro International Group, which makes deep water well equipment, beating an earlier bid by a group of private equity firms.
A months-long strike ended as workers at American Axle and Manufacturing approved a four-year contract that the U.A.W.’s president had described as subpar but “the best we can do.”
In what has become a regular show in the hearing rooms on Capitol Hill, oil company executives took a second day of lashings over the rising price of gasoline.
Serious management failures by superiors allowed a rogue trader at Société Générale to commit the biggest fraud in financial history, according to an internal report to be released Friday.
Avastin, already widely used to treat other types of cancer, is leading a pack of new drugs that look promising as treatments for brain cancer, one of the deadliest forms of cancer.
Standard & Poor’s indicated it was likely to cut the credit ratings of nine big airlines in the latest sign that the outlook for the airline industry is darkening.
Two insiders had said Kyphon, a unit of Medtronic, improperly persuaded hospitals to keep people overnight for a simple outpatient procedure to repair small fissures of the spine.
The company nominated 9 of its 10 existing directors for re-election to its board, setting the stage for a showdown with dissident shareholders at its annual meeting, which has been postponed until late July.
Japan says it wants to send at least 220,000 tons of rice to the Philippines, and possibly Africa to help the poor. But critics are pointing to a trade issue.
A sensor is being tested by the Federal Aviation Administration to detect debris that can damage airplane engines on takeoff or even lead to plane crashes.
The British Bankers’ Association is trying to determine whether some of the 16 banks that it polls each day to set the rate at which banks borrow money from each other provided false or misleading rates.
The founder of American Capital, an investment firm in Maryland, finds himself swept into the story of deadly, contaminated heparin imported from China.
As shares in Bell Canada declined, many investors and analysts turned their attention to alternatives for the company should its $51.8 billion privatization fail.